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In this work we looked at whether and how mitochondria isolated from Saccharomyces cerevisiae (SCM) oxidize D-lactate. We found that:
(1) externally added D-lactate causes oxygen uptake by SCM with P/O ratio equal to 1.5; in the presence of antimycin A (AA), P/O ratio was
1.8, differently in the presence of the non-penetrant a-cyanocinnamate (a-CCN) no P/O ratio could be measured. Consistently,
mitochondrial electrical membrane potential (Dw) generation was found, due to externally added D-lactate in the presence of antimycin A,
but not of a-CCN.
(2) SCM oxidize D-lactate in two different manners:
(i) via inner membrane D-lactate dehydrogenase which leads to D-lactate oxidation without driving Dw generation and ATP
synthesis and
(ii) via the matrix D-lactate dehydrogenase, which drives Dw generation and ATP synthesis by using taken up D-lactate.
(3) Pyruvate newly synthesised in the mitochondrial matrix is exported via the novel D-lactate/pyruvate antiporter. D-Lactate/pyruvate antiport
proved to regulate the rate of pyruvate efflux in vitro.
(4) The existence of the D-lactate/H+ symporter is also proposed as shown by mitochondrial swelling.
The D-lactate carriers and D-lactate dehydrogenases could account for the removal of the toxic methylglyoxal from cytosol, as well as for
the D-lactate-dependent gluconeogenesis.
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Despite the huge number of papers dealing with the
mitochondrial bioenergetics, transport and genetics, the
knowledge of the role of mitochondria in energy metab-
olism is far from being completely elucidated (see Ref.
[1]). This certainly applies to D-lactate metabolism. In this
regard, we have recently shown the D-lactate oxidation in
rat liver mitochondria, where the putative D-lactate dehy-
drogenase is located, as well as export of the newly
synthesised metabolites due to the occurrence of three
separate carriers [2].
The existence of mitochondrial D-lactate metabolism
has been already proposed in yeast [3–5]. In yeast, D-
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alase I in the methylglyoxal pathway in cytosol [6],
where D-lactate dehydrogenase (Dld3) is localized [7].
However, the D-lactate fate is far from being completely
elucidated: indeed, two mitochondrial D-lactate dehydro-
genases have been reported in Saccharomyces cerevisiae:
one of them located in the inner membrane (Dld1) with
the bulk of the protein residing as a folded domain in the
intermembrane space [8], and the other in the matrix
(Dld2) [7].
The existence of two separate enzymes for D-lactate
mitochondrial metabolism poses the question as to
whether and how (i) the D-lactate metabolizing enzymes
differ from each other with respect to D-lactate-linked
energy production and (ii) D-lactate can enter mitochon-
dria to be oxidized in addition to D-lactate synthesised in
the matrix from lactoyl-glutathione owing to glyoxalase
II reaction [9].
We show that Dld1-dependent D-lactate oxidation
occurs without electrical membrane potential (Dw) gener-
ation in a manner not stimulated by ADP and that D-lactate
can enter Saccharomyces cerevisiae mitochondria (SCM)
with D-lactate oxidation, occurring in the matrix via Dld2,
coupled with ATP synthesis. The occurrence of the novel
D-lactate/pyruvate antiporter is also shown.2. Materials and methods
2.1. Materials
All reagents and enzymes were from Sigma (St. Louis,
MO, USA) except Zymoliase (ICN) and Bacto Yeast
Extract (Difco). Substrates were used as Tris salts at pH
7–7.4.
2.2. Strains and growth conditions
ATCC 18790 S. cerevisiae strains were used in this study.
In some experiments, wild-type PSY142 and PSY142
derivative of tetradelete (dld1::LEU2, dld2::kanMX4,
dld3::URA3, cyb2::LYS2) and Dld1 (dld2::kanMX4,
dld3::URA3), were used [7] kindly purchased by professor
Ronald Butow. Cells were grown aerobically as reported in
Ref. [10].
2.3. Isolation of mitochondria and protein assay
SCM were isolated and checked for their intactness as
in Ref. [10] with mitochondrial protein measured as in
Ref. [11]. Mitochondrial respiration was measured at 25
jC with a Clark oxygen electrode in a 1.5-ml closed vessel
containing 0.6 M mannitol, 20 mM HEPES–Tris pH 7.4,
10 mM potassium phosphate, 2 mM MgCl2, 1 mM EDTA,
5 mg/ml BSA. When added with 0.1 mM ADP, SCM
show respiratory control index (RCI) 2.1F 0.14, as mea-sured in five different experiments, with 5 mM succinate,
used as a respiratory substrate.
2.4. Safranin response assay
Safranin response assay was monitored at 25 jC
essentially as in Ref. [12], by measuring safranin O
fluorescence changes (kex 520 nm, kem 570 nm) by means
of a PERKIN-ELMER LS-50B spectrofluorimeter. The
reaction medium (2 ml) contained SCM (0.2 mg), 0.6 M
sucrose, 5 mM MgCl2, 20 mM Tris–HCl pH 7.20,
1.25 AM safranin O.
2.5. Dld1 assay
Dld1 activity was assayed photometrically by means of a
Jasco V-560 spectrophotometer at 600 nm, as in Ref. [7].
Briefly, SCM (0.2 mg protein) were incubated at 25 jC in 2
ml of a medium consisting of 0.6 M sucrose, 1 mM MgCl2,
20 mM HEPES–Tris, 10 mM Tris–HCl pH 7.20, in the
presence of 30 AM phenazine methosulfate (PMS) and
50 AM 2,6 dichloroindophenol (DCIP) plus 1 mM cyanide
(KCN). After exhaustion of endogenous substrates, the
reaction was started by addition of 0.1 mM D-lactate. The
rates of decrease of absorbance at 600 nm due to DCIP
reduction were obtained as tangent at the initial part of
experimental curve and expressed as nmol DCIP reduced/
minmg protein (e600 = 21 mM 1 cm 1).
2.6. Absorbance measurements
Oxaloacetate (OAA) and citrate appearance outside mi-
tochondria was monitored essentially as in Ref. [13] by
using the oxaloacetate detecting system consisting of 200
AM NADH plus malate dehydrogenase (MDH) (1 e.u.) and
the citrate detecting system consisting of 200 AM OAA, 0.2
mM HCO3
, 1 mM ATP, 200 AM NADH plus citrate liase (1
e.u.) and MDH (1 e.u.) and then, following photometrically,
NADH oxidation caused by externally added D-lactate,
which per se proved to have no effect on the enzymatic
reactions and on the absorbance measured at 340 nm.
Pyruvate appearance in the extramitochondrial phase,
due to externally added D-lactate, was monitored, essential-
ly as in Ref. [13], by using the pyruvate detecting system
(PDS) consisting of 0.2 mM NADH and L-lactate dehy-
drogenase (L-LDH) (0.5 e.u), either in the absence or
presence of antimycin A (AA; 2 Ag). The rate of pyruvate
appearance, due to D-lactate addition to SCM, was followed
photometrically as decrease in the absorbance at 340 nm,
due to NADH oxidation and measured as tangent at the
initial part of experimental curve; the rate was expressed as
nmol NADH oxidized/minmg mitochondrial protein.
Where indicated, 0.2 mM NADPH was used instead of
NADH. The e340 value measured for NAD(P)H, under our
experimental conditions, was 6.3 mM 1 cm 1. Control
was made that all the compounds used in this paper do not
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outside mitochondria.
2.7. Cytochrome c reduction assay
Cytochrome c reduction was monitored photometrically
at 25 jC using the JASCO V-560 and V-520 dual-beam
dual-wavelength (550–530 nm) [14]. SCM were suspended
in 2 ml of a medium consisting of 0.6 M sucrose, 1 mM
MgCl2, 20 mM HEPES–Tris, 10 mM Tris–HCl pH 7.20,
with the reaction started by the substrate (5 mM succinate orFig. 1. (A) Oxygen uptake by SCM due to externally added D-lactate. SCM (0.2 mg
2. At the arrows, D-lactate (1 mM), ADP (0.1 mM), AA (2 Ag), KCN (1 mM) and a
as natoms O/minmg protein. (B) SCM membrane potential generation due to ex
ml of the medium reported in Section 2 in the absence or presence of AA (2 Ag) or
as a function of time. At the arrows, D-lactate (1 mM) and FCCP (1.25 AM) wer1 mM D-lactate) addition. Cytochrome c reduction was
expressed as DA at the completion of the reaction.
2.8. Swelling measurements
Swelling experiments were performed at 25 jC, essen-
tially as in Ref. [15]. SCM (0.1 mg) were rapidly added to
isotonic solutions of ammonia salts whose pH was adjusted
to 7.2 and the decrease in the absorbance at 546 nm
continuously recorded as a function of time by means of a
Jasco V-630 spectrophotometer.protein) were incubated at 25 jC in 1 ml of the medium reported in Section
-CCN (1 mM) were added. The rate of oxygen consumption was expressed
ternally added D-lactate. SCM (0.2 mg protein) were incubated at 25 jC in 2
a-CCN (1 mM), with continuous measurement of the safranin fluorescence
e added.
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The experimental data were plotted by means of Grafit
(Erithacus Software).
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externally added D-lactate to SCM. SCM (0.2 mg protein) were incubated at
25 jC in 2 ml of the standard medium (0.6 M sucrose, 0.02 M HEPES–Tris
pH 7.2, 0.01 M Tris–HCl, 1 mM MgCl2) in the presence of the pyruvate
detecting system (PDS) consisting of 0.2 mM NADPH and L-LDH (1.5
e.u.). Where indicated, 0.1 mM D-lactate was added to SCM. The numbers
along the traces report the rate of pyruvate appearance in the
extramitochondrial phase expressed as nmol NADPH oxidized/minmg
protein. When present, 2 Ag AA (b) or 1 mM a-CCN (c) was added to
SCM 1 min before D-lactate addition.3. Results
3.1. D-Lactate oxidation in SCM
We investigated how isolated SCM can oxidize D-lactate
(Fig. 1A). SCM were added with D-lactate (1 mM) and
measurements of oxygen uptake made in both State 4 and
State 3 in the presence of 0.1 mM ADP: in a typical
experiment, oxygen uptake was found to occur at a rate
equal 70 natoms O/minmg protein (state 4); externally
added ADP (0.1 mM) proved to cause increase of the rate of
oxygen uptake up to 112 (state 3), with RCI equal to 1.6 and
P/O ratio equal to 1.5 (Fig. 1A, a). When ADP phosphor-
ylation was complete, the rate of oxygen uptake was 69
natoms O/minmg protein (state 4 post ADP). AA (2 Ag),
an inhibitor of complex III of the respiratory chain, proved
to cause 30% decrease of the rate of oxygen consumption,
as measured in state 4 post ADP, which was completely
blocked due to KCN (1 mM), a potent inhibitor of complex
IV. When SCM were incubated in the presence of AA (Fig.
1A, b), the rate of oxygen uptake were 50 natoms O/
minmg protein in state 4 and 100 natoms O/minmg
protein in state 3, with both P/O ratio and RCI equal to 2;
externally added a-cyanocinnamate (a-CCN; 1 mM), a
potent inhibitor of the pyruvate transport in mammalian
mitochondria [1], proved to block oxygen uptake complete-
ly. In the presence of 1 mM a-CCN (Fig. 1A, c), the rate of
oxygen uptake was 22 natoms O/minmg protein, with
about 70% inhibition with respect to the control rate in state
4, but no ADP stimulation of the rate of oxygen consump-
tion was found, which was totally blocked as a result of AA
addition. In the same experiment, when measuring succinate
oxidation, P/O ratio was 2; no or 100% of inhibition was
found in the presence of either a-CCN or AA, respectively
(data not shown).
In five experiments, carried out with different SCM
preparations, D-lactate P/O ratios were 1.4F 0.1 and
1.8F 0.2 in the absence or presence of AA respectively;
they proved to differ from each other, as judged by a
statistical analysis carried out according to the Student’s t
test (P < 0.02); in the same experiments, P/O ratio mean, as
measured by using succinate as a respiratory substrate, was
equal to 1.9F 0.1.
3.2. D-Lactate-dependent mitochondrial Dw generation
The D-lactate capability to generate mitochondrial Dw in
SCM was checked as a function of time by measuring
fluorescence of safranin O used as Dw probe (Fig. 1B).
D-Lactate (5 mM) was found to generate Dw, as shown bythe decrease of the safranin O fluorescence; as expected, the
uncoupler FCCP proved to abolish Dw. AAwas found to be
ineffective to inhibit the rate of Dw generation due to
D-lactate, whereas a-CCN proved to completely prevent
Dw generation by D-lactate. In a control experiment, Dw
generation due to externally added succinate (5 mM) was
Fig. 4. Dld1 failure in generating Dw and reducing cytochrome c in
mitochondria from yeast lacking of Dld2 and Dld3. (A) Dld1-SCM (0.2 mg
protein) were incubated at 25 jC in 2 ml of the standard medium in the
presence of 1.25 AM safranin O. At the arrows, D-lactate (5 mM) or
succinate (5 mM) and FCCP (1.25 AM) were added to SCM. When present,
AA (2 Ag) or MYXO (3 AM) was added 1 min before succinate addition.
(B) Dld1-SCM (1 mg protein) were incubated at 25 jC in 2 ml of the
standard medium with absorbance measured as a function of time as
reported in Section 2. At the arrows, D-lactate (5 mM), KCN (1 mM),
ascorbate (ASC; 8 mM) and TMPD (0.2 mM), as well as succinate (5 mM)
(see inset), were added to SCM.
Fig. 3. D-Lactate oxidation due to the inner membrane Dld1. SCM (0.2 mg
protein) were incubated at 25 jC in 2 ml of the standard medium in the
presence of 50 AM DCIP and 30 AM PMS, plus 1 mM KCN. At the arrow,
0.1 mM D-lactate was added to SCM (see inset). When present, 2 Ag AA, 3
AM MYXO or 0.3 mM a-CCN was added to SCM, 30 s before D-lactate
addition. The rate of D-lactate oxidation was measured in the presence of
increasing D-lactate concentration and expressed as nmol of DCIP oxidized/
minmg protein.
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(not shown).
3.3. The addition of D-lactate to SCM causes pyruvate
appearance in the extramitochondrial phase
In order to gain further insight into mitochondrial
D-lactate metabolism, the capability of D-lactate to cause
appearance outside SCM of certain metabolites, including
pyruvate, oxaloacetate and citrate, was checked as in Refs.
[13,16].
The pyruvate concentration in the extramitochondrial
phase was negligible, since no change of NADPH (used
instead of NADH that is rapidly oxidized by SCM) absor-
bance was found in the presence of L-LDH (Fig. 2). As a
result of D-lactate (1 mM) addition, a fast decrease of
absorbance was found, which showed the pyruvate appear-
ance outside SCM. In agreement with Ref. [2], a possible
explanation is that D-lactate can enter SCM; inside mito-
chondria, due to the matrix enzyme Dld2, pyruvate is
formed, which in turn can exit in exchange with further
D-lactate. However, pyruvate appearance in the extramito-
chondrial phase can be also due to the activity of the inner
membrane enzyme Dld1.
In order to ascertain how pyruvate production, due to
D-lactate oxidation, occurs in SCM, the pyruvate appear-
ance in the extramitochondrial phase was measured in the
presence of either AA or a-CCN, previously shown to
inhibit oxygen uptake by SCM in a different manner. The
rate of pyruvate appearance due to D-lactate addition toSCM was 300 nmol/minmg (Fig. 2, trace a). In the
presence of AA (2 Ag) or a-CCN (1 mM), the rates were
65% (Fig. 2, trace b) and 35% (Fig. 2, trace c) of the
control, respectively. Consistently, no pyruvate appearance
was found in the presence of AA plus a-CCN. Control
was made that a-CCN and D-lactate fail to inhibit the
activity and to be a substrate, respectively, of the L-LDH
used in the pyruvate detecting system.
No oxaloacetate and citrate efflux was found due to
D-lactate addition to SCM (data not shown).
3.4. AA-sensitive D-lactate oxidation by SCM
In order to ascertain whether the D-lactate oxidation, due
to the inner membrane Dld1, is AA-sensitive, we measured
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nm. As a control, we checked that succinate oxidation (that
occurs in the matrix side of the inner mitochondrial mem-
brane) was detectable only after Triton X-100 (0.1%)
addition, which allows interaction between DCIP and the
succinate dehydrogenase complex, by dissolving the mito-
chondrial membranes (not shown); contrarily, externally
added D-lactate (0.1 mM) was oxidized in absence of Triton
X-100 at a rate equal to 93 nmol/minmg protein due to
Dld1 located in the intermembrane side of the inner mito-
chondrial membrane (see inset of Fig. 3). D-Lactate oxida-
tion by Dld1 was found to be completely prevented by AA
(2 Ag), but totally insensitive to either externally added
a-CCN (1 mM) or myxothiazol (MYXO), which acts on
the quinol-oxidizing center (Qo) of Complex III, thus block-
ing electron flow. The dependence of the rate of D-lactateFig. 5. D-Lactate/pyruvate antiport in SCM. (A) Inhibition by a-CCN of the pyru
mg protein) were incubated were incubated at 25 jC in 2 ml of the standard medium
was added to SCM in the absence or presence of increasing concentrations of a-CC
and vo being the rates in the presence and absence of a-CCN
. (B) Inhibition by
D-lactate. SCM (0.2 mg protein) was incubated as described in the legend of (A). D
concentrations of cyanide.oxidation, as catalyzed by Dld1 on increasing substrate
concentration, was then investigated. Saturation kinetics
were found with Vmax and Km values equal to 128F 5.1
nmol/minmg protein and 0.02F 0.04 mM, respectively
(Fig. 3).
In order to better investigate the role of Dld1 in D-lactate
oxidation, in another set of experiments SCM isolated from a
PSY142 strain, containing only the gene coding for Dld1
(Dld1-SCM) due to both dld2 and dld3 gene deletion, were
used. Mitochondria were found to oxidase D-lactate (1 mM)
at a low rate (16F 4 natoms O/minmg protein) with no
stimulation caused by externally added ADP (0.1 mM), in a
manner inhibited by AA, but not by MYXO (not shown).
Consistently, no Dw generation was found as a result of
D-lactate (5 mM), but not of succinate (5 mM) addition (Fig.
4A). Either AA or MYXO was found to prevent membranevate appearance outside SCM due to externally added D-lactate. SCM (0.2
in the presence of the PDS plus 2 Ag AA. Either 0.1 mM or 1 mM D-lactate
N. The inset reports the plot of 1/i against 1/a-CCN where i = 1 vi/vo, vi
cyanide of the pyruvate appearance outside SCM due to externally added
-Lactate (1 mM) was added to SCM in the absence or presence of increasing
Fig. 6. Dependence of the rate of D-lactate/pyruvate antiporter on D-lactate
concentration. SCM (0.2 mg protein) were incubated at 25 jC in 2 ml of
the standard medium in the presence of PDS plus 2 Ag AA. The rate of
D-lactate/pyruvate antiport was measured as a function of increasing
D-lactate concentration and expressed as nmol NADH oxidized/minmg
protein.
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Moreover, AA, as well as MYXO, proved to prevent Dw
generation by succinate, but not by D-lactate in wild-type
PSY142 strain (not shown). In another experiment, in Dld1-
SCM, cytochrome c reduction was found due to succinate
(5 mM) (inset Fig. 4B), but not to D-lactate; further addition
of the respiratory pair, ascorbate (ASC; 8 mM) plus
N,N,NV,NV-tetramethyl-p-phenylenediamine (TMPD; 0.2
mM), was found to cause cytochrome c reduction (Fig. 4B).
3.5. a-CCN-sensitive D-lactate oxidation by SCM
In order to investigate the mechanism by which pyruvate
appears outside SCM in a manner not dependent on Dld1, a
set of experiments was carried out in an AA-containing
medium. The rate of pyruvate appearance due to externally
added D-lactate (0.1 and 1 mM) was measured in the
absence or presence of increasing concentrations of either
a-CCN (Fig. 5A) or cyanide (Fig. 5B), used to find out
whether the rate of pyruvate appearance outside SCM
depends on the electron flow along the respiratory chain.
a-CCN was found to inhibit in a competitive manner the
pyruvate appearance (Ki about 0.1 mM) (Fig. 5A), thus
suggesting the presence of a carrier mediated transport.
Interestingly, the y intercepts of the lines, obtained by fitting
the experimental points determined in the presence of
increasing a-CCN concentrations, were found to coincide
with the points obtained in the absence of inhibitor. In
accordance with the control strength criterion [1,17], this
shows that the a-CCN-sensitive D-lactate transport con-
trols the rate of the measured process. The data of Fig. 5A
were plotted as 1/i against 1/[Inhibitor], where the fractional
inhibition i = 1 vi/vo (see inset). In both cases, the y
intercept was 1, showing that a-CCN completely prevents
D-lactate uptake. This experiment also shows that no pyru-
vate efflux can occur in a manner non-sensitive to a-CCN,
i.e. via diffusion. Consistently, no inhibition was found due
to the cyanide in 0–0.4 AM range, whereas for higher
cyanide concentrations, the electron flow along the respira-
tory chain proved to control the rate of pyruvate efflux.
The dependence of the rate of pyruvate efflux as a
function of increasing D-lactate concentrations was investi-
gated (Fig. 6). As expected, if transport occurs mediated by
a carrier protein, saturation kinetics were found with Vmax
and Km values equal to 400F 6.4 nmol/minmg protein
and 0.03F 0.002 mM, respectively.
In another set of experiments, mitochondria were isolated
from PSY142 S. cerevisiae wild type and from tetradelete
strain (TD-SCM) depleted of the genes coding for all the
enzymes that can metabolize D- and L-lactate (see Section
2). Contrarily to PSY142 wild type mitochondria, TD-SCM
were found to be unable both to oxidize D-lactate (not
shown) and to cause pyruvate efflux (see inset of Fig. 7).
To check the occurrence of the D-lactate/pyruvate antiporter,
TD-SCM were added with alanine (ALA; 5 mM) and 2-
oxoglutarate (2-OG; 2.5 mM), thus providing the substratepair for the mitochondrial alanine aminotransferase [18].
Externally added D-lactate (1 mM) proved to cause a
pyruvate efflux (Fig. 7). Such a pyruvate appearance proved
to be inhibited by a-CCN and completely prevented by
aminooxyacetate (AOA; 1 mM), a powerful inhibitor of
transaminase that can enter mitochondria, but not by cyclo-
serine (CYCLOSER; 0.5 mM), a transaminase inhibitor that
cannot enter mitochondria [18].
3.6. D-Lactate can enter SCM itself
In order to check whether the transport paradigm,
already showed to occur in many transport processes [1],
also applies to D-lactate traffic across the SCM membranes,
i.e. to check whether D-lactate can enter SCM itself, in a
manner independent on the pyruvate efflux, perhaps in a
proton-compensated symport, swelling experiments were
carried out by suspending SCM in 0.3 mM ammonium
D-lactate as in Ref. [12]. SCM were found to swell in
ammonium D-lactate solution with extent and efficiency
higher than that measured with NH4-L-lactate, even though
lower than that in ammonium-Pi solution (Fig. 8). As
mitochondrial swelling in isotonic salt solutions is due to
salt electro-neutral entrance into the matrix, we investigat-
ed whether D-lactate enters SCM in a proton-compensated
manner. Thus, SCM swelling in ammonium D-lactate
solutions was monitored in the presence of certain ion-
ophores under experimental conditions designed to selec-
tively affect either DpH or Dw (Table 1, Experiment I).
Both nigericin, that collapses DpH, without affecting Dw,
and valinomycin, that increases Dw thus reducing DpH in
the absence of K+ ions, were found to inhibit the rate of
Table 1
SCM swelling in isoosmotic ammonium salt solutions
Substrate Addition vo (DA456/min) vo (%C)
Experiment I
NH4-D-lactate none 0.142 100
NH4-D-lactate nigericin 0.129 91
NH4-D-lactate valinomycin 0.112 78
NH4-D-lactate KCl 0.103 73 [100]
NH4-D-lactate valinomycin +KCl 0.126 89 [122]
Experiment II
NH4-D-lactate none 0.100 100
NH4-D-lactate a-CCN
 0.451 460
NH4-D-lactate pyruvate 0.184 189
NH4-D-pyruvate none 0.99 100
NH4-D-pyruvate a-CCN
 0.21 21
NH4-D-pyruvate D-lactate 0.99 100
Experiment I: SCM (0.2 mg protein) were incubated at 25 jC in 2 ml of 0.3
M ammonium D-lactate (NH4-D-lactate). SCM swelling in NH4-D-lactate
was measured either in the absence (none addition) or presence of 1 Ag
valinomycin or 0.1 nmol nigericin. SCM swelling in 0.3 M NH4-D-lactate
plus 0.02 M KCl, either in the absence or presence of 1 Ag valinomycin,
was also measured.
Experiment II: SCM (0.2 mg protein) were incubated at 25 jC in 2 ml of
either 0.3 M NH4-D-lactate or 0.3 M ammonium pyruvate (NH4-pyruvate).
SCM swelling in NH4-D-lactate was measured either in the absence or
presence of 1 mM pyruvate or 1 mM a-CCN, whereas SCM swelling in
0.3 M NH4-pyruvate was followed either in the absence or presence of
either 1 mM D-lactate or 1 mM a-CCN.
Fig. 7. The capability of externally added D-lactate to cause pyruvate efflux
from TD-SCM. TD-SCM (0.2 mg protein) were incubated at 25 jC in 2 ml
of the standard medium plus 5 mM alanine (ALA), 2.5 mM 2-oxoglutarate
(2-OG) and 1 mM KCN, in the presence of the PDS plus 2 Ag AA. At the
arrow, 1 mM D-lactate was added to SCM. When present, 0.3 mM
a-CCN, 1 mM aminooxyacetate (AOA) or 0.5 mM cycloserine
(CYCLOSER) was added to SCM, 1 min before D-lactate addition. The
rate of pyruvate appearance in the extramitochondrial phase due to D-lactate
addition was expressed as nmol NADH oxidized/minmg protein.
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increase of DpH by valinomycin in the presence of K+
ions, which per se decrease the rate of swelling, an
enhancement of the rate of swelling was found.
In another experiment (Table 1, Experiment II), compar-
ison was made between SCM swelling in D-lactate and
pyruvate ammonia solutions with respect to their sensitivityFig. 8. SCM swelling in isoosmotic ammonium salt solutions. SCM (0.2 mg
protein) were incubated at 25 jC in 1.7 ml of the following solutions: 0.3 M
ammonium D-lactate (NH4-D-lactate), 0.3 M ammonium L-lactate (NH4-L-
lactate), 0.2 M ammonium phosphate (NH4-Pi), 0.6 M mannitol.to pyruvate and D-lactate respectively, and to a-CCN.
Interestingly, both pyruvate and a-CCN (1 mM each) were
found to significantly increase the rate of D-lactate swelling,
whereas mitochondrial swelling in NH4-pyruvate was
inhibited by a-CCN, but insensitive to 1 mM D-lactate.
Control was also made that D-lactate, pyruvate and a-CCN
themselves do not cause any change in the SCM absorbance
(not shown).4. Discussion
We show that SCM can oxidize externally added D-
lactate by virtue of the two D-lactate oxidizing enzymes
already reported [7,8] and that the intramitochondrial reac-
tion is made possible by the occurrence of D-lactate carrier-
mediated transport across the mitochondrial membrane.
Thus, Dld2 is shown to oxidize D-lactate taken up by
SCM in addition to the D-lactate synthesised in the matrix
due to glyoxalase II [9].
Since D-lactate oxidation and, consequently, pyruvate
production outside SCM can be due to both inner membrane
Dld1 and matrix Dld2, we have developed a model system
in which Dld1 and Dld2 reactions can be investigated
separately: Dld1 can be monitored in the presence of a-
CCN, which can prevent D-lactate uptake by SCM and
intramitochondrial metabolism by inhibiting D-lactate trans-
port in a competitive manner, whereas Dld2 reaction can be
selectively monitored in the presence of AA, which com-
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the intramitochondrial D-lactate oxidation. Consistently, AA
proved to inhibit oxygen uptake in state 4 post ADP by
impairing D-lactate oxidation via Dld1 (Fig. 1a); such an
inhibition results in increase in oxidative phosphorylation as
shown in Fig. 1b where P/O ratio was 2.
The two D-lactate oxidations differ from each other
because the Dld1-dependent oxidation occurs without Dw
generation and ATP synthesis, whereas the Dld2-dependent
oxidation takes place in a coupled manner with P/O ratio
not different from that calculated for succinate, but with the
exception of the AA sensitivity. At present, how this can
occur must remain a matter of speculation, however, it has
already been reported in other systems that Dw, which
bocks re-oxidation of cytochrome b at the Qi site, only
incompletely inhibits steady-state cytochrome c reduction
by cytochrome bc1 (cyt bc1) complex [19,20]. Recently, the
existence of multiple Q-cycle bypass reactions at the Qo site
of isolated yeast cyt bc1 complex has been shown; partic-
ularly, it was suggested that a semiquinone pool could
escape from Qo site and reduce cytochrome c directly in
an AA-insensitive manner [21].
At present, we have no indication on how the external
Dld1 works: unfortunately, the low Q amount in SCM
sample prevents any measurement of Q redox state change;
however, the above data, together with initial evidence that
D-lactate added to mitochondria from yeast in which the
genes for the dld2 and dld3 were deleted were unable to
reduce cytochrome c and to generate Dw as well as to
synthesise ATP, strongly suggests that this enzyme is
different from the matrix dehydrogenase as the nature of
the reaction is concerned. Moreover, any role of Complex
III in oxidizing D-lactate via Dld1 can be ruled out as
MYXO, which impairs electron flow across the bc1 com-
plex, does not affect D-lactate oxidation. The possibility that
the external Dld1 is an AA-sensitive oxidase is actually
under investigation.
When comparing the growth rate of wild-type PSY142
and of PSY142 strain containing only Dld1 in a medium
consisting of 2% D–L-lactate, we did not find any signifi-
cant reduction of the growth rate. Since in this strain the
only D-lactate-metabolizing enzyme Dld1 is not energy-
competent, we assume that the growth is sustained by the
L-lactate and by pyruvate and other compounds deriving
from D-lactate metabolism.
In order to study D-lactate uptake by SCM, use was made
of spectroscopic techniques under conditions in which
mitochondrial metabolism is mostly active, thus allowing
for monitoring mitochondrial reactions and traffic of the
newly synthesised substrates across mitochondrial mem-
brane [1]. Pyruvate appearance outside SCM occurs with
a rate that is a measurement of the novel D-lactate/pyruvate
antiport; in fact, the control strength criterion was success-
fully applied by using a-CCN and we could measure the
rate of the pyruvate efflux as the rate of NAD(P)H oxida-
tion. In agreement with the existence of a carrier-mediatedtransport, saturation kinetics was found for D-lactate/
pyruvate antiport.
We propose also the existence of a carrier-mediated
transport for D-lactate in a proton-compensated manner.
Such a proposal derives from the spontaneous stereo-
specific swelling in D-lactate ammonia solution and is
further confirmed by the ionophore swelling sensitivity:
under conditions in which DpH is partially abolished due
to the presence of either nigericin or valinomycin (in the
absence of K+ ions) and to the activity of the H+/K+ antiport
[22], inhibition of the rate of the swelling was found.
Contrarily, under conditions in which Dw decreases with a
consequent DpH increase, an enhancement of the rate of
swelling was found. That D-lactate can enter in a proton-
compensated manner is further suggested by the strong
stimulation of SCM swelling in NH4-D-lactate due to a-
CCN, which increases matrix osmolite concentration, pos-
sibly by preventing the efflux of pyruvate due to the
antiporter D-lactate/pyruvate and by the activation due to
pyruvate which is assumed to stimulate D-lactate/pyruvate
antiport. That pyruvate carrier can play a role in the transport
of D-lactate can be ruled out by the lack of D-lactate
activation of mitochondrial swelling in NH4-pyruvate and
by inhibition found by 1 mM a-CCN. On the other hand,
the different Ki values were 0.1 and 1 mM [3] for D-lactate/
pyruvate antiport and pyruvate/H+ symport, respectively,
further confirming that D-lactate/H+ and pyruvate/H+ sym-
porters differ from each other.
Notice that the a-CCN inhibition of SCM swelling in
ammonium pyruvate rules out that the D-lactate symport
occurs via the pyruvate carrier.
Inhibition studies, not reported in details, show that the
D-lactate/pyruvate carrier is different from the succinate/
malate and the fumarate/malate translocators [23] and from
the adenine nucleotide translocator.
Thus, we propose that the pyruvate appearance in the
extramitochondrial phase is a result of the proton- compen-
sated D-lactate uptake, pyruvate formation inside the matrix
due to the presence of the matrix Dld2, and to the occurrence
of the D-lactate/pyruvate antiporter. Consistently, pyruvate
stimulation of mitochondrial swelling in ammonium D-lactate
was found, as expected when one counteranion can catalyt-
ically cause the establishment of an antiport process [24].
Interestingly, we show that the D-lactate/pyruvate anti-
porter is a constitutive protein present in mitochondria from
yeast depleted of genes coding for the three D-lactate
dehydrogenases, as well as for L-lactate cytochrome c
oxidoreductase, since externally added D-lactate can cause
efflux of pyruvate, newly synthesised in the matrix via
transaminase from alanine, in a a-CCN-sensitive manner.
This paper gives a first insight into the two mitochondrial
enzymes that accomplish D-lactate oxidation.We are forced to
propose that the two mitochondrial enzymes can exhibit a
different role in yeast metabolism. Indeed, the matrix Dld2 is
shown here to contribute toDw generation and ATP synthesis
by using D-lactate taken up by mitochondria via the two
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competent’’, perhaps participating, together with cytosolic
Dld3, in the gluconeogenesis in the absence of energy require-
ment in cytosol where pyruvate carboxylase is located [25].
We suggest that the two D-lactate carriers play a different
physiological role, the symporter being devoted to accom-
plish D-lactate catabolism and the antiporter to supply
pyruvate in the cytosol for gluconeogenesis.AcknowledgementsWe wish to thank Prof. Ronald Butow for gifts of strains
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